^
BIOMARKER:
CCDC6-RET fusion
i
Other names: RET, Ret Proto-Oncogene, Proto-Oncogene Tyrosine-Protein Kinase Receptor Ret, Cadherin-Related Family Member 16, Rearranged During Transfection, RET Receptor Tyrosine Kinase, Cadherin Family Member 12, Proto-Oncogene C-Ret, CDHF12, CDHR16, PTC, Ret Proto-Oncogene (Multiple Endocrine Neoplasia And Medullary Thyroid Carcinoma 1, Hirschsprung Disease), Multiple Endocrine Neoplasia And Medullary Thyroid Carcinoma 1, Hirschsprung Disease 1, RET-ELE1, HSCR1, MEN2A, MEN2B, RET51, MTC1, CCDC6, Coiled-Co
Entrez ID:
CCDC6-RET fusion
NSCLC
RET inhibitor
Sensitive
:
C3
CCDC6-RET fusion
NSCLC
vandetanib
Sensitive
:
C3
CCDC6-RET fusion
NSCLC
crizotinib
Sensitive
:
C3
CCDC6-RET fusion
CRC
RXDX-105
Sensitive
:
C3
CCDC6-RET fusion
NSCLC
sunitinib
Sensitive
:
C3
CCDC6-RET fusion
NSCLC
nintedanib
Sensitive
:
C3
CCDC6-RET fusion
NSCLC
cabozantinib capsule
Sensitive
:
C3
CCDC6-RET fusion
NSCLC
lenvatinib
Sensitive
:
C3
CCDC6-RET fusion
Thyroid Gland Anaplastic Carcinoma
selpercatinib
Sensitive
:
C4
CCDC6-RET fusion
NSCLC
RXDX-105
Sensitive
:
D
CCDC6-RET fusion
LUAD
cabozantinib capsule
Sensitive
:
D
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our